Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 126 entries
View as:

ER-One: A Double-blind Trial of Erector Spinae Block (ESP) Versus Paravertebral Block (PVB) Before Breast Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT04827030 Org: User:
Start: 06/28/21 End: 07/14/23 Due: 07/14/24

Development of an EORTC Immune Checkpoint Inhibitor-specific Quality of Life Item List: Phase 1 & 2

Phase: N/A Priority: Normal
NCT ID: NCT05554432 Org: User:
Start: 10/12/22 End: 04/30/25 Due: 04/30/26

Optimizing Bronchopulmonary Cancer Screening

Phase: N/A Priority: Normal
NCT ID: NCT06439901 Org: User:
Start: 01/17/25 End: 01/17/33 Due: 01/17/34

Study of Circulating Tumoral DNA in Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01350908 Org: User:
Start: 04/30/11 End: 12/31/15 Due: 12/31/16

Test Semiquantitative Prostate Specific Antigen (PSA)

Phase: N/A Priority: Normal
NCT ID: NCT00853710 Org: User:
Start: 03/31/09 End: 07/31/09 Due: 07/31/10

Study for the Reliability and Validity of the EORTC PATSAT-C33 and the EORTC OUT-PATSAT7 Questionnaires

Phase: N/A Priority: Normal
NCT ID: NCT05989191 Org: User:
Start: 11/15/19 End: 03/30/25 Due: 03/30/26

Digital Phenotyping in Young Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05011721 Org: User:
Start: 09/20/21 End: 03/03/25 Due: 03/03/26

Evaluation of the Impact of Chemotherapy on Body Odor in Adolescents and Young Adults in Oncology

Phase: N/A Priority: Normal
NCT ID: NCT04899505 Org: User:
Start: 10/21/21 End: 05/12/25 Due: 05/12/26

Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02843386 Org: User:
Start: 06/23/09 End: 06/12/20 Due: 06/12/21

Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether)

Phase: N/A Priority: Normal
NCT ID: NCT04728113 Org: User:
Start: 07/16/20 End: 01/22/25 Due: 01/22/26

Nivolumab in Association With Radiotherapy and Cisplatin in Locally Advanced Cervical Cancers Followed by Adjuvant Nivolumab for up to 6 Months

Phase: N/A Priority: Normal
NCT ID: NCT03298893 Org: User:
Start: 11/27/17 End: 03/07/22 Due: 03/07/23

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01956695 Org: User:
Start: 09/18/13 End: 01/11/18 Due: 01/11/19

ProActIF-01 Trial: Feasibility Study of an Individualized Program of Nutrition and Adapted Physical Activity in Frail Patients With Advanced Digestive Cancers

Phase: N/A Priority: Normal
NCT ID: NCT05441163 Org: User:
Start: 04/08/23 End: 04/08/28 Due: 04/08/29

FErtility, PrEgnancy, contRaceptIon After Breast Cancer in France

Phase: N/A Priority: Normal
NCT ID: NCT03884413 Org: User:
Start: 03/08/18 End: 03/31/21 Due: 03/31/22

Feasibility of Supportive Care Needs in Patients With Advanced Solid Cancer in a Therapeutic Trial

Phase: N/A Priority: Normal
NCT ID: NCT04896099 Org: User:
Start: 06/07/21 End: 12/15/21 Due: 12/15/22

LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)

Phase: N/A Priority: Normal
NCT ID: NCT04446962 Org: User:
Start: 10/30/20 End: 08/30/35 Due: 08/30/36

Predictive Response to Chemotherapy (FOLFOX or FOLFIRI) by ex Vivo Culture 3D Technique in Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02849106 Org: User:
Start: 05/31/11 End: 01/31/15 Due: 01/31/16

Fibroblast Before and After Neoadjuvant Chemo-radiotherapy in Patient With Locally Advanced Rectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02849158 Org: User:
Start: 06/09/17 End: 06/30/23 Due: 06/30/24

Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)

Phase: N/A Priority: Normal
NCT ID: NCT03496402 Org: User:
Start: 04/20/18 End: 08/19/27 Due: 08/19/28

Real Life Study Evaluating the Clinical and Organisational Impact of Moovcare® Lung Connected Medical Device in Lung Cancer Patients : REAL-MOOV-LUNG

Phase: N/A Priority: Normal
NCT ID: NCT04934865 Org: User:
Start: 10/07/21 End: 02/28/25 Due: 02/28/26

Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification

Phase: N/A Priority: Normal
NCT ID: NCT02864563 Org: User:
Start: 10/04/08 End: 07/31/23 Due: 07/31/24

SIOPEN BIOPORTAL, An International Registry Linked to a Virtual Biobank for Patients With Peripheral Neuroblastic Tumours

Phase: N/A Priority: Normal
NCT ID: NCT05192980 Org: User:
Start: 11/02/23 End: 11/02/38 Due: 11/02/39

Exenteration: Quality of Life Study and Rehabilitation Rate According to the Reconstruction Technique (ETRE)

Phase: N/A Priority: Normal
NCT ID: NCT04994730 Org: User:
Start: 05/25/21 End: 05/25/22 Due: 05/25/23

Use of Specific Genetic Alteration s of Tumoral Cells Identified by the Next Generation Sequencing Techniques (NGS) to Follow Peripheral Samples of Children With Metastatic and/or High Risk Solid Tumor - NGSKids

Phase: N/A Priority: Normal
NCT ID: NCT02546453 Org: User:
Start: 09/30/14 End: 01/31/21 Due: 01/31/22

68Ga-FAPI-46 PET/CT for Predicting Histological Response in Triple-negative Breast Cancer (FAP-IT)

Phase: N/A Priority: Normal
NCT ID: NCT06349512 Org: User:
Start: 10/14/24 End: 11/30/27 Due: 11/30/28